000			01607 a2200457 4500
005			20250517222224.0
264		0	_c20190322
008			201903s 0 0 eng d
022			_a1521-0111
024	7		_a10.1124/mol.117.110924 _2doi
040			_aNLM _beng _cNLM
100	1		_aBombardo, Marta
245	0	0	_aInhibition of Class I Histone Deacetylases Abrogates Tumor Growth Factor _h[electronic resource]
260			_bMolecular pharmacology _c08 2018
300			_a793-801 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBenzamides _xadministration & dosage
650	0	4	_aCell Line
650	0	4	_aCeruletide _xadverse effects
650	0	4	_aDisease Models, Animal
650	0	4	_aFibrosis _xprevention & control
650	0	4	_aGene Expression Regulation
650	0	4	_aHistone Deacetylase Inhibitors _xadministration & dosage
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aPancreas _xdrug effects
650	0	4	_aPancreatic Stellate Cells _xcytology
650	0	4	_aPancreatitis, Chronic _xchemically induced
650	0	4	_aPyridines _xadministration & dosage
650	0	4	_aRats
650	0	4	_aTransforming Growth Factor beta _xmetabolism
700	1		_aChen, Rong
700	1		_aMalagola, Ermanno
700	1		_aSaponara, Enrica
700	1		_aHills, Andrew P
700	1		_aGraf, Rolf
700	1		_aSonda, Sabrina
773	0		_tMolecular pharmacology _gvol. 94 _gno. 2 _gp. 793-801
856	4	0	_uhttps://doi.org/10.1124/mol.117.110924 _zAvailable from publisher's website
999			_c28508823 _d28508823